CoChat

Alzheimer’s Disease: Pathophysiology and Applications of Magnetic Nanoparticles as MRI Theranostic Agents

Open access
Amiri, Houshang, Saeidi, Kolsoum, Borhani, Parvin, Manafirad, Arash, Ghavami, Mahdi, Zerbi, Valerio · 2013 · ACS Chemical Neuroscience
Cited by 113

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease (AD) is the most common form of dementia. During the recent decade, nanotechnology has been widely considered, as a promising tool, for theranosis (diagnosis and therapy) of AD. Here we first discuss pathophysiology and characteristics of AD with a focus on the amyloid cascade hypothesis. Then magnetic nanoparticles (MNPs) and recent works on their applications in AD, focusing on the superparamagnetic iron oxide nanoparticles (SPIONs), are reviewed. Furthermore, the amyloid-nanoparticle interaction is highlighted, with the scope to be highly considered by the scientists aiming for diagnostics and/or treatment of AD employing nanoparticles. Furthermore, recent findings on the "ignored" parameters (e.g., effect of protein "corona" at the surface of nanoparticles on amyloid-β (Aβ) fibrillation process) are discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/cn4001582

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Research works printed but not linked: 116

  1. Selkoe D. J., 2003, Annu. Rev. Pharmacol. Toxicol., 43, 545, 10.1146/annurev.pharmtox.43.100901.140248 · DOI · Paper page
  2. Mahmoudi M., 2012, Chem. Commun., 48, 3957, 10.1039/c2cc30213f · DOI
  3. Mahmoudi M., 2012, ACS Nano, 6, 2656, 10.1021/nn300042m · DOI · Paper page
  4. Helzner E. P., 2008, Neurology, 71, 1489, 10.1212/01.wnl.0000334278.11022.42 · DOI · Paper page
  5. Folstein M. F., 1975, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  6. Berger G., 2008, J. Geriatr. Psychiatry Neurol., 21, 250, 10.1177/0891988708324939 · DOI
  7. Wilson R. S., 2006, Neuroepidemiology, 26, 61, 10.1159/000090250 · DOI · Paper page
  8. Mahmoudi M., 2012, Trends Biotechnol., 30, 609, 10.1016/j.tibtech.2012.08.007 · DOI
  9. Van Dam D., 2006, Nat. Rev. Drug Discovery, 5, 956, 10.1038/nrd2075 · DOI · Paper page
  10. Allinson T. M., 2003, J. Neurosci. Res., 74, 342, 10.1002/jnr.10737 · DOI · Paper page
  11. Wisniewski T., 2010, Biochim. Biophys. Acta, Mol. Basis Dis., 1802, 847, 10.1016/j.bbadis.2010.05.004 · DOI · Paper page
  12. Weller R. O., 2003, Neurol. Res., 25, 611, 10.1179/016164103101202057 · DOI · Paper page
  13. Maat-Schieman M., 2005, Neuropathology, 25, 288, 10.1111/j.1440-1789.2005.00631.x · DOI · Paper page
  14. Crawford F., 1998, Exp. Neurol., 150, 159, 10.1006/exnr.1997.6743 · DOI
  15. Niwa K., 2001, Am. J. Physiol.: Heart Circ. Physiol., 281, H2417
  16. de la Torre J. C., 2000, Neurobiol. Aging, 21, 331, 10.1016/S0197-4580(00)00111-1 · DOI · Paper page
  17. Crawford F., 1998, FEBS Lett., 436, 445, 10.1016/S0014-5793(98)01170-3 · DOI · Paper page
  18. Thomas T., 1997, J. Cardiovasc. Pharmacol., 30, 517, 10.1097/00005344-199710000-00017 · DOI
  19. Burke S. N., 2010, Trends Neurosci., 33, 153, 10.1016/j.tins.2009.12.003 · DOI · Paper page
  20. Samuel W., 1994, Neurology, 44, 2081, 10.1212/WNL.44.11.2081 · DOI · Paper page
  21. Rapp P. R., 1996, Proc. Natl. Acad. Sci. U.S.A., 93, 9926, 10.1073/pnas.93.18.9926 · DOI · Paper page
  22. Dong H., 2007, J. Comp. Neurol., 500, 311, 10.1002/cne.21176 · DOI · Paper page
  23. Rademakers R., 2003, Sci. World J., 3, 497, 10.1100/tsw.2003.39 · DOI · Paper page
  24. Tanzi R. E., 2001, Neuron, 32, 181, 10.1016/S0896-6273(01)00476-7 · DOI · Paper page
  25. Mayeux., 2003, Annu. Rev. Neurosci., 26, 81, 10.1146/annurev.neuro.26.043002.094919 · DOI · Paper page
  26. Van Duijn C. M., 1994, Genet. Epidemiol., 11, 539, 10.1002/gepi.1370110609 · DOI · Paper page
  27. Corder E. H., 1993, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
  28. Strittmatter W. J., 1993, Proc. Natl. Acad. Sci. U.S.A., 90, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
  29. Pitas R. E., 1987, J. Biol. Chem., 6, 63
  30. Xu P. T., 1999, Neurobiol. Dis., 6, 63, 10.1006/nbdi.1998.0213 · DOI · Paper page
  31. Mahley R. W., 2000, Annu. Rev. Genomics Hum. Genet., 1, 507, 10.1146/annurev.genom.1.1.507 · DOI · Paper page
  32. Tierney M. C., 1996, Neurology, 46, 149, 10.1212/WNL.46.1.149 · DOI · Paper page
  33. Mahley R. W., 2006, Proc. Natl. Acad. Sci. U.S.A., 103, 5644, 10.1073/pnas.0600549103 · DOI · Paper page
  34. McLean C. A., 1999, Ann. Neurol., 46, 860, 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
  35. Hardy J., 2002, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
  36. Li S., 2009, Neuron, 62, 788, 10.1016/j.neuron.2009.05.012 · DOI · Paper page
  37. Glenner G. G., 1984, Biochem. Biophys. Res. Commun., 120, 885, 10.1016/S0006-291X(84)80190-4 · DOI · Paper page
  38. Glenner G. G., 1989, Prog. Clin. Biol. Res., 317, 857
  39. Ikeda S., 1989, Lab. Invest., 60, 113
  40. Goldgaber D., 1987, Science, 235, 877, 10.1126/science.3810169 · DOI · Paper page
  41. St George-Hyslop P. H., 1987, Science, 235, 885, 10.1126/science.2880399 · DOI · Paper page
  42. Levy E., 1990, Science, 248, 1124, 10.1126/science.2111584 · DOI · Paper page
  43. Selkoe D. J., 1998, Trends Cell Biol., 8, 447, 10.1016/S0962-8924(98)01363-4 · DOI · Paper page
  44. Bonifacino J. S., 2003, Annu. Rev. Biochem., 72, 395, 10.1146/annurev.biochem.72.121801.161800 · DOI · Paper page
  45. Yamazaki T., 1996, J. Cell Sci., 109, 999, 10.1242/jcs.109.5.999 · DOI · Paper page
  46. Koo E. H., 1996, J. Cell Sci., 109, 991, 10.1242/jcs.109.5.991 · DOI · Paper page
  47. Stokin G. B., 2006, Annu. Rev. Biochem., 75, 607, 10.1146/annurev.biochem.75.103004.142637 · DOI · Paper page
  48. Tienari P., 1996, EMBO J., 15, 10.1002/j.1460-2075.1996.tb00907.x · DOI
  49. Roychaudhuri R., 2009, J. Biol. Chem., 284, 4749, 10.1074/jbc.R800036200 · DOI · Paper page
  50. Bernstein S. L., 2009, Nat. Chem., 1, 326, 10.1038/nchem.247 · DOI · Paper page
  51. Colletier J. P., 2011, Proc. Natl. Acad. Sci. U.S.A., 108, 16938, 10.1073/pnas.1112600108 · DOI · Paper page
  52. Rahimi F., 2008, Curr. Alzheimer Res., 5, 319, 10.2174/156720508784533358 · DOI · Paper page
  53. Sakono M., 2010, FEBS J., 277, 1348, 10.1111/j.1742-4658.2010.07568.x · DOI · Paper page
  54. Lasagna-Reeves C. A., 2011, J. Biol. Chem., 286, 22122, 10.1074/jbc.M111.236257 · DOI · Paper page
  55. Glabe C. G., 2006, Neurology, 66, S74, 10.1212/01.wnl.0000192103.24796.42 · DOI · Paper page
  56. Williams R., 2001, Coord. Chem. Rev., 216, 583, 10.1016/S0010-8545(00)00398-2 · DOI · Paper page
  57. Laurent S., 2012, RSC Adv., 2, 5008, 10.1039/c2ra01374f · DOI
  58. 10.1038/srep02782 · DOI
  59. Tottey S., 2007, Molecular microbiology of heavy metals
  60. Chamberlain R., 2009, Magn. Reson. Med., 61, 1158, 10.1002/mrm.21951 · DOI · Paper page
  61. Zerbi V., 2012, Brain Struc. Funct., 218, 1805
  62. Fazil M., 2012, J. Drug Targeting, 20, 97, 10.3109/1061186X.2011.607499 · DOI
  63. Gabathuler R., 2010, Neurobiol. Dis., 37, 48, 10.1016/j.nbd.2009.07.028 · DOI · Paper page
  64. Roney C., 2005, J. Controlled Release, 108, 193, 10.1016/j.jconrel.2005.07.024 · DOI · Paper page
  65. Tanifum E. A., 2012, PloS One, 7, e48515, 10.1371/journal.pone.0048515 · DOI · Paper page
  66. Beckmann N., 2011, J. Neurosci., 31, 1023, 10.1523/JNEUROSCI.4936-10.2011 · DOI · Paper page
  67. Petiet A., 2012, Neurobiol. Aging, 33, 1533, 10.1016/j.neurobiolaging.2011.03.009 · DOI
  68. Poduslo J. F., 2002, Neurobiol. Dis., 11, 315, 10.1006/nbdi.2002.0550 · DOI · Paper page
  69. Sillerud L. O., 2013, J. Alzheimer’s Dis., 34, 349, 10.3233/JAD-121171 · DOI · Paper page
  70. Cai W., 2007, Small, 3, 1840, 10.1002/smll.200700351 · DOI · Paper page
  71. Cao C. Y., 2013, Sci. Rep., 3, 1024, 10.1038/srep01024 · doi:10.1038/srep01024
  72. Kanal E., 2012, Magn. Reson. Imaging Clin. North Am., 20, 625, 10.1016/j.mric.2012.08.004 · doi:10.1016/j.mric.2012.08.004
  73. Othman M., 2011, Org. Biomol. Chem., 9, 4367, 10.1039/c1ob00015b · doi:10.1039/c1ob00015b
  74. Laurent S., 2004, Bioconjugate Chem., 15, 99, 10.1021/bc034114m · doi:10.1021/bc034114m
  75. Amiri H., 2011, Magn. Reson. Med., 66, 1715, 10.1002/mrm.22959 · DOI
  76. Amiri H., 2011, Nanoscale, 3, 1022, 10.1039/C0NR00603C · DOI · Paper page
  77. Hosseini F., 2013, Colloids Surf., B, 652, 10.1016/j.colsurfb.2012.10.035 · doi:10.1016/j.colsurfb.2012.10.035
  78. Wang Y. X., 2011, Quant. Imaging Med. Surg., 1, 35
  79. Yanagisawa D., 2011, Neuroscience, 184, 120, 10.1016/j.neuroscience.2011.03.071 · DOI
  80. Houshang Amiri, M. S., Andor Veltein, Mark J., van Uden, I., Jolanda, M., and de Vries, Arend Heerschap. (2013) Cell Tracking by 19F MRI:Technical Aspects and Challenges towards Clinical Applications.Submitted for publication. · DOI
  81. Krol S., 2013, Chem. Rev., 113, 1877, 10.1021/cr200472g · DOI · Paper page
  82. Mahmoudi M., 2013, ACS Chem. Neurosci., 4, 475, 10.1021/cn300196n · DOI · Paper page
  83. Cabaleiro-Lago C., 2010, ACS Chem. Neurosci., 1, 279, 10.1021/cn900027u · DOI · Paper page
  84. Amiri H., 2013, Nanoscale, 5, 8656, 10.1039/c3nr00345k · DOI · Paper page
  85. Dorota Walczyk B. F., 2010, J. Am. Chem. Soc., 5761
  86. Mahmoudi M., 2011, Chem. Rev., 111, 5610, 10.1021/cr100440g · DOI · Paper page
  87. Lesniak A., 2012, ACS Nano, 6, 5845, 10.1021/nn300223w · DOI · Paper page
  88. Mahmoudi M., 2013, ChemBioChem, 14, 568, 10.1002/cbic.201300007 · DOI
  89. Mahmoudi M., 2012, Nanoscale, 4, 7322, 10.1039/c2nr31657a · DOI · Paper page
  90. Mahmoudi M., 2013, ACS Nano, 7, 6555, 10.1021/nn305337c · DOI · Paper page
  91. Ghavami M., 2013, ACS Chem. Neurosci., 4, 375, 10.1021/cn300205g · DOI
  92. Mahmoudi M., 2011, ACS Nano, 5, 7263, 10.1021/nn2021088 · DOI · Paper page
  93. Laurent S., 2013, J. Colloid Interface Sci., 392, 431, 10.1016/j.jcis.2012.10.005 · DOI
  94. Rauch J., 2012, Sci. Rep., 2, 868, 10.1038/srep00868 · DOI
  95. Mahmoudi M., 2012, Nanoscale, 4, 5461, 10.1039/c2nr31185b · DOI
  96. Mahmoudi M., 2011, Chem. Rev., 111, 253, 10.1021/cr1001832 · DOI · Paper page
  97. Mahmoudi M., 2010, Int. J. Biomed. Nanosci. Nanotechnol., 164, 10.1504/IJBNN.2010.034651 · DOI · Paper page
  98. Mahmoudi M., 2010, J. Iran. Chem. Soc., 7, S1, 10.1007/BF03246181 · DOI
  99. Nighoghossian N., 2007, Stroke, 38, 303, 10.1161/01.STR.0000254548.30258.f2 · DOI · Paper page
  100. Saleh A., 2007, Stroke, 38, 2733, 10.1161/STROKEAHA.107.481788 · DOI · Paper page
  101. Dousset V., 2006, AJNR Am. J. Neuroradiol., 27, 1000
  102. Mahmoudi M., 2011, ACS Chem. Neurosci., 2, 118, 10.1021/cn100100e · DOI · Paper page
  103. Mahmoudi M., 2011, Adv. Drug Delivery Rev., 63, 24, 10.1016/j.addr.2010.05.006 · DOI · Paper page
  104. Mahmoudi M, 2010, Superparamagnetic iron oxide nanoparticles for biomedical applications
  105. Brambilla D., 2012, ACS Nano, 6, 5897, 10.1021/nn300489k · DOI · Paper page
  106. Skaat H., 2009, Nanotechnology, 20, 225106, 10.1088/0957-4484/20/22/225106 · DOI
  107. Skaat H., 2009, Biochem. Biophys. Res. Commun., 386, 645, 10.1016/j.bbrc.2009.06.110 · DOI
  108. Skaat H., 2009, J. Biomed. Mater. Res., Part A, 91, 342, 10.1002/jbm.a.32232 · DOI
  109. Andersson B. V., 2012, Biochem. Biophys. Res. Commun., 419, 682, 10.1016/j.bbrc.2012.02.077 · DOI
  110. Bellova A., 2010, Nanotechnology, 21, 065103, 10.1088/0957-4484/21/6/065103 · DOI
  111. Mahmoudi M., 2012, Chem. Rev., 112, 2323, 10.1021/cr2002596 · DOI · Paper page
  112. Conti B., 2013, Cell, 152, 671, 10.1016/j.cell.2013.01.050 · DOI
  113. Xiao R., 2013, Cell, 152, 806, 10.1016/j.cell.2013.01.020 · DOI · Paper page
  114. Vinters H. V., 1998, Acta Neuropathol., 95, 235, 10.1007/s004010050793 · DOI
  115. Deng Z. J., 2011, Nature Nanotechnol., 6, 39, 10.1038/nnano.2010.250 · DOI · Paper page
  116. Ahn H. J., 2010, Proc. Natl. Acad. Sci. U.S.A., 107, 21812, 10.1073/pnas.1010373107 · DOI · Paper page

Cited by

See all 113

Metadata

Authors
Amiri, H., Saeidi, K., Borhani, P., Manafirad, A., Ghavami, M., & Zerbi, V.
Venue
ACS Chemical Neuroscience
Published
2013-09-26
Volume
4
Issue
11
Pages
1417-1429
ISSN
1948-7193 (ISSN-L)
OpenAlex
W2064534908
Cited by
113
References
50
FWCI
4.28
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alzheimer’s Disease: Pathophysiology and Applications of Magnetic Nanoparticles as MRI Theranostic Agents. https://app.cochat.ai/papers/10.1021/cn4001582
The paper
Amiri, H., Saeidi, K., Borhani, P., Manafirad, A., Ghavami, M., & Zerbi, V. (2013). Alzheimer’s Disease: Pathophysiology and Applications of Magnetic Nanoparticles as MRI Theranostic Agents. ACS Chemical Neuroscience. https://doi.org/10.1021/cn4001582

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.